Literature DB >> 19215820

Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.

Christine Ellingsen1, Tormod A M Egeland, Kristine Gulliksrud, Jon-Vidar Gaustad, Berit Mathiesen, Einar K Rofstad.   

Abstract

PURPOSE: Patients with advanced cervical cancer and highly hypoxic primary tumors show increased frequency of locoregional treatment failure and poor disease-free and overall survival rates. The potential usefulness of gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA)-based dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in assessing tumor hypoxia noninvasively was investigated in the present preclinical study. METHODS AND MATERIALS: CK-160 and TS-415 human cervical carcinoma xenografts transplanted intramuscularly (i.m.) or subcutaneously (s.c.) in BALB/c nu/nu mice were subjected to DCE-MRI and measurement of fraction of radiobiologically hypoxic cells. Tumor images of K(trans) (the volume transfer constant of Gd-DTPA) and v(e) (the extracellular volume fraction of the imaged tissue) were produced by pharmacokinetic analysis of the DCE-MRI data. Fraction of radiobiologically hypoxic cells was measured by using the paired survival curve method.
RESULTS: Fraction of radiobiologically hypoxic cells differed significantly among the four tumor groups. The mean values +/- SE were determined to be 44% +/- 7% (i.m. CK-160), 77% +/- 10% (s.c. CK-160), 23% +/- 5% (i.m. TS-415), and 52% +/- 6% (s.c. TS-415). The four tumor groups differed significantly also in K(trans), and there was an unambiguous inverse relationship between K(trans) and fraction of radiobiologically hypoxic cells. On the other hand, significant differences among the groups in v(e) could not be detected.
CONCLUSIONS: The study supports the clinical development of DCE-MRI as a method for assessing the extent of hypoxia in carcinoma of the cervix.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215820     DOI: 10.1016/j.ijrobp.2008.10.062

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  Magnetic resonance in the era of molecular imaging of cancer.

Authors:  John C Gore; H Charles Manning; C Chad Quarles; Kevin W Waddell; Thomas E Yankeelov
Journal:  Magn Reson Imaging       Date:  2011-04-27       Impact factor: 2.546

2.  Diffusion-weighted MRI-derived ADC values reflect collagen I content in PDX models of uterine cervical cancer.

Authors:  Anette Hauge; Catherine S Wegner; Jon-Vidar Gaustad; Trude G Simonsen; Lise Mari K Andersen; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-11-11

Review 3.  The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.

Authors:  Bernard Gallez
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

4.  DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.

Authors:  Anette Hauge; Catherine S Wegner; Jon-Vidar Gaustad; Trude G Simonsen; Lise Mari K Andersen; Einar K Rofstad
Journal:  J Transl Med       Date:  2017-11-03       Impact factor: 5.531

5.  DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.

Authors:  Kjersti V Lund; Trude G Simonsen; Gunnar B Kristensen; Einar K Rofstad
Journal:  Radiat Oncol       Date:  2020-04-15       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.